| Original language | English |
|---|---|
| Pages (from-to) | S366-S368 |
| Journal | Translational Cancer Research |
| Volume | 6 |
| DOIs | |
| State | Published - Mar 1 2017 |
Bibliographical note
Funding Information:This work was supported by the Shared Resources of the University of Kentucky Markey Cancer Center (P30CA177558), grants from NIH (CA125454 and CA188118), DoD (BC140733P1), and Mary Kay Ash Foundation.
Funding
This work was supported by the Shared Resources of the University of Kentucky Markey Cancer Center (P30CA177558), grants from NIH (CA125454 and CA188118), DoD (BC140733P1), and Mary Kay Ash Foundation.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | CA188118, CA125454 |
| U.S. Department of Defense | BC140733P1 |
| Mary Kay Ash Foundation | |
| University of Kentucky Markey Cancer Center | P30CA177558 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Oncology
- Radiology Nuclear Medicine and imaging
- Cancer Research
Fingerprint
Dive into the research topics of 'KDM1 links nuclear GSK3β to epigenetic alterations'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver